Table 2.
Category | Logistic Regression |
Group | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|---|---|
PC | HC | OR (95% CI) | p | OR (95% CI) | p a | |||
FBG | All | Continuous scale | 54 | 279 | 1.03 (1.02~1.04) | <0.0001 | 1.04 (1.03~1.05) | <0.0001 |
FBG (≥126 mg/dL) | 28 | 26 | 10.5 (5.37~20.5) | <0.0001 | 13.4 (6.24~28.7) | <0.0001 | ||
FBG (<126 mg/dL) | 26 | 253 | Ref | Ref | ||||
Male | Continuous scale | 26 | 134 | 1.03 (1.01~1.04) | <0.0001 | 1.03 (1.02~1.05) | <0.0001 | |
FBG (≥126 mg/dL) | 14 | 20 | 6.65 (2.69~16.4) | <0.0001 | 7.70 (2.65~22.5) | 0.0002 | ||
FBG (<126 mg/dL) | 12 | 114 | Ref | Ref | ||||
Female | Continuous scale | 28 | 145 | 1.05 (1.02~1.07) | <0.0001 | 1.05 (1.03~1.08) | <0.0001 | |
FBG (≥126 mg/dL) | 14 | 6 | 23.2 (7.69~69.8) | <0.0001 | 32.3 (9.28~112.4) | <0.0001 | ||
FBG (<126 mg/dL) | 14 | 139 | Ref | Ref |
ORs and 95% CIs were evaluated for analyzing the relationship between FBG concentration and PC risk using univariate and multivariate logistic regression analyses. FBG levels were categorized as ≥126 mg/dL and <126 mg/dL. a p-Values were adjusted for sex, age, BMI, and smoking status. One FBG data value was missing from each of the two groups. Abbreviations: FBG, fasting blood glucose; PC, pancreatic cancer; HC, healthy control; OR, odds ratio; CI, confidence interval; Ref, reference value.